Yogendra Kanthi Selected Research

Sudden Death

1/2021

IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yogendra Kanthi Research Topics

Disease

22	COVID-19 01/2023 - 01/2020
20	Thrombosis (Thrombus) 09/2023 - 11/2013
9	Venous Thrombosis (Deep-Vein Thrombosis) 09/2023 - 01/2016
9	Inflammation (Inflammations) 01/2023 - 11/2013
6	Thromboinflammation 09/2023 - 01/2021
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2023 - 01/2019
4	Pneumonia (Pneumonitis) 01/2023 - 01/2016
3	Thrombophilia 01/2022 - 09/2020
3	Infections 12/2021 - 01/2020
2	VEXAS syndrome 02/2024 - 10/2021
2	Hemorrhage 09/2023 - 04/2015
2	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 04/2020
2	Lung Diseases (Lung Disease) 01/2021 - 07/2020
2	Atherosclerosis 01/2020 - 08/2015
1	Vascular System Injuries 09/2023
1	Leukemia 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Pathologic Constriction (Stenosis) 01/2022
1	Severe Acute Respiratory Syndrome 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Atrial Remodeling 01/2021
1	Ventricular Tachycardia 01/2021
1	Sudden Death 01/2021
1	Critical Illness (Critically Ill) 10/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020

Drug/Important Bio-Agent (IBA)

8	AutoantibodiesIBA 02/2022 - 01/2018
6	AntibodiesIBA 02/2022 - 02/2009
6	Antiphospholipid AntibodiesIBA 02/2022 - 01/2017
5	EnzymesIBA 02/2024 - 01/2019
5	Histones (Histone)IBA 07/2021 - 01/2020
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2022 - 05/2020
4	Cell Adhesion MoleculesIBA 02/2022 - 01/2016
4	CytokinesIBA 12/2021 - 04/2020
4	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
3	InflammasomesIBA 09/2023 - 01/2019
3	Complement System Proteins (Complement)IBA 01/2022 - 10/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
3	Peroxidase (Myeloperoxidase)IBA 05/2020 - 01/2020
3	Cell-Free Nucleic AcidsIBA 05/2020 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 01/2020
3	Adenosine Diphosphate (ADP)IBA 06/2017 - 11/2013
3	Adenosine Triphosphate (ATP)IBA 06/2017 - 11/2013
2	Colchicine FDA LinkGeneric 09/2023 - 01/2023
2	AnticoagulantsIBA 01/2023 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 05/2022
2	E-SelectinIBA 11/2021 - 01/2016
2	defibrotideIBA 07/2021 - 01/2021
2	Plasminogen Activator Inhibitor 1IBA 01/2021 - 12/2020
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2021 - 12/2020
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 12/2020
2	Immunoglobulin M (IgM)IBA 01/2021 - 09/2020
2	Carrier Proteins (Binding Protein)IBA 11/2020 - 09/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020 - 09/2020
2	fibrin fragment D (D-dimer)IBA 10/2020 - 05/2020
2	FibrinIBA 10/2020 - 12/2017
2	ChromatinIBA 04/2020 - 01/2020
2	serum P-component (CIt)IBA 04/2020 - 01/2020
2	Oxidants (Oxidizing Agents)IBA 04/2020 - 01/2020
2	NucleotidesIBA 01/2019 - 01/2016
2	P-SelectinIBA 01/2019 - 01/2016
2	Adenosine Monophosphate (AMP)IBA 01/2016 - 11/2013
1	canakinumab FDA Link 09/2023
1	Histone MethyltransferasesIBA 01/2023
1	Syk KinaseIBA 01/2023
1	Thromboplastin (Tissue Factor)IBA 01/2023
1	Interleukin-1 (Interleukin 1)IBA 01/2023
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	Interferon Type IIBA 12/2021
1	AndrogensIBA 11/2021
1	MineralocorticoidsIBA 11/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 11/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2021
1	VaccinesIBA 11/2021
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	PotassiumIBA 01/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2020
1	Hemostatics (Antihemorrhagics)IBA 10/2020
1	estropipate (Ogen)FDA LinkGeneric 10/2020
1	Thrombin FDA Link 10/2020
1	Prothrombin (Factor II)IBA 09/2020
1	PhosphatidylserinesIBA 09/2020
1	Glycoproteins (Glycoprotein)IBA 09/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	Heparinoids (Heparinoid)IBA 05/2020
1	TroponinIBA 05/2020
1	Ferritins (Ferritin)IBA 05/2020
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019
1	InterleukinsIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2023 - 04/2015
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 07/2020
2	Ligation 01/2019 - 12/2017
1	Stents 01/2022